-- EO-1022 is comprised of seribantumab, an anti-HER3 monoclonal antibody, and an MMAE payload –-- Following recently signed global license agreement with Synaffix, EO-1022 leverages the company's GlycoConnect® and HydraSpace® ADC technologies for glycan site-specific conjugation and SYNstatin E™ linker-payload --– Elevation Oncology expects to present EO-1022 preclinical data in 1H 2025 and to file an IND application in 2026 –BOSTON, Dec. 12, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an ...

Licensing agreement gives Elevation Oncology access to Synaffix's ADC technology for one program in combination with SYNstatin E™ Elevation Oncology nominates a novel HER3 ADC candidate EO-1022 leveraging its antibody as well as Synaffix's proprietary ADC development technologiesAMSTERDAM, Dec. 12, 2024 /PRNewswire/ -- Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therape ...

You won't be charged a penny during the free trial, so you have nothing to lose and everything to gain.If you want full access to our Portfolio and all our current Top Picks, feel free to join us at High Yield Landlord for a 2-week free trial.The Fed has already cut interest rates two times, and it is expected to cut rates again at the next meeting on December 18th.He is the leader of the investing group High Yield Landlord , where he shares his real-money REIT portfolio and transactions in real-time. Featu ...

Steady as she goes : Used to describe a ship sailing steady. It can be defined as being careful, steady, and being consistent.Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to do their own due diligence. I'm a Navy veteran who enjoys dividend investing in quality blue-chip stocks, ...

Gilead Sciences, Inc. (GILD) entered into an exclusive option and license agreement with Tubulis, a Germany-based biotech company.The collaboration is aimed at discovering and developing an antibody-drug conjugate (ADC) against a solid tumor target.Gilead’s shares have risen 14.2% year to date against the industry's decline of 6.9%.Image Source: Zacks Investment ResearchMore on GILD’s Deal With TubulisThe single-asset focused collaboration, license and option agreement combines Tubulis’ differentiated ADC p ...

Conservative Income Portfolio targets the best value stocks with the highest margins of safety. The volatility of these investments is further lowered using the best priced options. Our Enhanced Equity Income Solutions Portfolio is designed to reduce volatility while generating 7-9% yields.Our previous takes on Agree Realty Corporation (NYSE: ADC ) have been on the neutral side, and we have only come away with a “hold” rating. The stockTrapping Value provides Covered Calls, and Preferred Stock Trader covers ...

With just a month left to the year, the S&P 500 is up 26% in 2024. Unless there's some major news over the next few weeks, the year will close out with a strong gain. Can it continue into 2025? There are indications that it can, such as an improving retail landscape and falling interest rates -- and there are indications that it can't, such as historically high valuations.What should investors do? One thing you can do when it's unclear what's going to happen next (which is basically all the time) is make su ...

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ADC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice ...

Defence's Proprietary Accum Technology Ready to License to Companies Developing Antibody Drug Conjugates (ADC)November 29, 2024 6:00 PM EST | Source: Defence Therapeutics Inc.Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug delivery technologies in addition to ...

Realty Income (O) is the 800-pound gorilla in the net lease sector, with a massive $50 billion market cap. It's four times larger than its next closest competitor, and more than six times the size of fast-growing peer Agree Realty (ADC -0.07%). Should Agree Realty be aiming to take Realty Income's place?What does Realty Income do?Like Agree Realty, Realty Income is a net lease real estate investment trust (REIT). Net lease properties are generally single tenant assets for which the tenant is responsible for ...